Top Markets
Coin of the day
Orient Pharma Co., Ltd. Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd.

4166
Rank in Stocks #18704
Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global... Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global pharmaceutical company engaged in the research, development, production, and sales of medicinal products. Its extensive pipeline addresses diverse therapeutic areas, including psychiatric disorders such as anti-psychotics and psychostimulants, neurological conditions like Parkinson's and Alzheimer's diseases, and treatments for sialorrhea, tuberculosis, and attention deficit hyperactivity disorder (ADHD). Beyond its drug portfolio, the company is also at the forefront of developing advanced drug delivery technologies, featuring multi-stage controlled release systems, transdermal patches, orally disintegrating tablets, sustained-release formulations, and microgranule technology.
Share Price
$0.77907619
Market Cap
$189.34M
Change (1 day)
0.41%
Change (1 year)
-7.35%
Country
TW
Trade Orient Pharma Co., Ltd. (4166)

Category

P/S ratio for Orient Pharma Co., Ltd. (4166)
P/S ratio as of 2026 TTM: 0
According to Orient Pharma Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Orient Pharma Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors